Beta-amyloid precursor protein and early-onset Alzheimer's disease

Ciba Found Symp. 1996:199:170-80. doi: 10.1002/9780470514924.ch11.

Abstract

One of the major pathological hallmarks of Alzheimer's disease is the deposition in the brain parenchyma and cerebral blood vessel walls of amyloid beta-protein, a 4kDa proteolytic product of the longer beta-amyloid precursor protein (APP). Six different single base mutations in the APP gene have been reported causing early-onset Alzheimer's disease (age at onset < or = 65 years) or related amyloidosis in a small number of families. Cell transfection experiments using wild-type and mutant APP cDNA indicated that APP mutations result in the production of more or longer, aggregation prone, A beta peptides.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / genetics
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / physiopathology
  • Amino Acid Sequence
  • Amyloid beta-Protein Precursor / genetics*
  • Amyloid beta-Protein Precursor / metabolism*
  • Amyloidosis / genetics
  • Amyloidosis / metabolism
  • Amyloidosis / physiopathology
  • Brain / blood supply
  • Brain / metabolism
  • Cerebrovascular Circulation
  • Down Syndrome / metabolism
  • Humans
  • Molecular Sequence Data
  • Mutation*

Substances

  • Amyloid beta-Protein Precursor